<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000467824"><TermName>5-HT3 receptor antagonist</TermName><TermPronunciation>(… reh-SEP-ter an-TA-guh-nist)</TermPronunciation><TermDefinition><DefinitionText>A type of drug used to treat certain types of irritable bowel syndrome and relieve nausea and vomiting. It is a type of antiemetic. Also called 5-hydroxytryptamine 3 receptor antagonist and type 3 serotonin receptor antagonist.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000716782" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;5-HT3 receptor antagonist&quot;" language="en" id="_3"/><MediaLink ref="CDR0000716783" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;antagonista del receptor 5-HT3&quot;" language="es" id="_4"/><SpanishTermName>antagonista del receptor 5-HT3</SpanishTermName><SpanishTermDefinition><DefinitionText>Tipo de medicamento que se usa para tratar ciertos tipos de síndrome del colon irritable, y aliviar náuseas y vómitos. Es un tipo de antiemético. También se llama antagonista del receptor de 5-hidroxitriptamina 3 y antagonista del receptor de seratonina tipo 3.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-05-11</DateFirstPublished><DateLastModified>2008-01-14</DateLastModified></GlossaryTerm>
